Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment.

[1]  Laura M Ensign,et al.  PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. , 2016, Advanced drug delivery reviews.

[2]  C. Sheridan.  Exosome cancer diagnostic reaches market , 2016, Nature Biotechnology.

[3]  Stefan Van Aelst,et al.  Melanoma addiction to the long non-coding RNA SAMMSON , 2016, Nature.

[4]  Carla Oliveira,et al.  Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine. , 2016, ACS nano.

[5]  F. Aqil,et al.  Bovine milk-derived exosomes for drug delivery. , 2016, Cancer letters.

[6]  Yang Yang,et al.  A microfluidic ExoSearch chip for multiplexed exosome detection towards blood-based ovarian cancer diagnosis. , 2016, Lab on a chip.

[7]  Pieter Vader,et al.  Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting , 2016, Journal of extracellular vesicles.

[8]  Heikki Saari,et al.  Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Myung Soo Kim,et al.  Using exosomes, naturally-equipped nanocarriers, for drug delivery. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[10]  X. Chen,et al.  Targeted exosome-mediated delivery of opioid receptor Mu siRNA for the treatment of morphine relapse , 2015, Scientific Reports.

[11]  Gary K. Schwartz,et al.  Tumour exosome integrins determine organotropic metastasis , 2015, Nature.

[12]  Dong Soo Lee,et al.  Noninvasive imaging of radiolabeled exosome-mimetic nanovesicle using 99mTc-HMPAO , 2015, Scientific Reports.

[13]  G. Warnock,et al.  Therapeutic potential of CAR-T cell-derived exosomes: a cell-free modality for targeted cancer therapy , 2015, Oncotarget.

[14]  Paolo Guazzi,et al.  Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches. , 2015, Methods.

[15]  L. O’Driscoll,et al.  miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity , 2015, Oncotarget.

[16]  Muhammad Nawaz,et al.  Stem cell-derived exosomes: roles in stromal remodeling, tumor progression, and cancer immunotherapy , 2015, Chinese journal of cancer.

[17]  Mansoor Amiji,et al.  Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases. , 2015, Clinical immunology.

[18]  Olivier Lantz,et al.  Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC , 2015, Oncoimmunology.

[19]  D. Peer,et al.  Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and non-malignant B-lymphocytes. , 2015, Cancer letters.

[20]  Qiyu Zhao,et al.  Increased anti-tumour activity by exosomes derived from doxorubicin-treated tumour cells via heat stress , 2015, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[21]  Christian Pilarsky,et al.  Glypican-1 identifies cancer exosomes and detects early pancreatic cancer , 2015, Nature.

[22]  Richa Gupta,et al.  Exosomes as drug delivery vehicles for Parkinson's disease therapy. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[23]  K. Mimori,et al.  Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer , 2015, British Journal of Cancer.

[24]  Molly M Stevens,et al.  Cell-derived vesicles for drug therapy and diagnostics: opportunities and challenges. , 2015, Nano today.

[25]  Marina Cretich,et al.  Digital detection of biomarkers assisted by nanoparticles: application to diagnostics. , 2015, Trends in biotechnology.

[26]  Jacco van Rheenen,et al.  In Vivo Imaging Reveals Extracellular Vesicle-Mediated Phenocopying of Metastatic Behavior , 2015, Cell.

[27]  Claudia Mongini,et al.  Emerging Roles of Exosomes in Normal and Pathological Conditions: New Insights for Diagnosis and Therapeutic Applications , 2015, Front. Immunol..

[28]  Henrik J Johansson,et al.  Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[29]  D. Andrews,et al.  Glioblastoma exosomes and IGF-1R/AS-ODN are immunogenic stimuli in a translational research immunotherapy paradigm , 2015, Cancer Immunology, Immunotherapy.

[30]  T. Anchordoquy,et al.  Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[31]  Michelle E. Hung,et al.  Stabilization of Exosome-targeting Peptides via Engineered Glycosylation* , 2015, The Journal of Biological Chemistry.

[32]  Hideo Saji,et al.  Quantitative analysis of tissue distribution of the B16BL6-derived exosomes using a streptavidin-lactadherin fusion protein and iodine-125-labeled biotin derivative after intravenous injection in mice. , 2015, Journal of pharmaceutical sciences.

[33]  Joshua N Leonard,et al.  Therapeutic applications of extracellular vesicles: clinical promise and open questions. , 2015, Annual review of pharmacology and toxicology.

[34]  Yuki Takahashi,et al.  Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice , 2015, Journal of extracellular vesicles.

[35]  Imre Mäger,et al.  Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting , 2015, Journal of extracellular vesicles.

[36]  Andrew F. Hill,et al.  Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper , 2015, Journal of extracellular vesicles.

[37]  Kit Lam,et al.  Single exosome study reveals subpopulations distributed among cell lines with variability related to membrane content , 2015, Journal of extracellular vesicles.

[38]  Y. Mo,et al.  Extracellular vesicles from bone marrow mesenchymal stem/stromal cells transport tumor regulatory microRNA, proteins, and metabolites , 2014, Oncotarget.

[39]  D. Bandyopadhyay.  Farmer to pharmacist: curcumin as an anti-invasive and antimetastatic agent for the treatment of cancer1 , 2014, Front. Chem..

[40]  Silvia Maria Doglia,et al.  Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[41]  G. Calin,et al.  The fusion of two worlds: Non-coding RNAs and extracellular vesicles - diagnostic and therapeutic implications (Review) , 2014, International journal of oncology.

[42]  C. Théry,et al.  Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. , 2014, Annual review of cell and developmental biology.

[43]  Muneesh Tewari,et al.  Quantitative and stoichiometric analysis of the microRNA content of exosomes , 2014, Proceedings of the National Academy of Sciences.

[44]  Thomas J. Anchordoquy,et al.  Surface Functionalization of Exosomes Using Click Chemistry , 2014, Bioconjugate chemistry.

[45]  H. Nakagawa,et al.  Antibody-coupled monolithic silica microtips for highthroughput molecular profiling of circulating exosomes , 2014, Scientific Reports.

[46]  J. Cooper,et al.  Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice , 2014, Movement disorders : official journal of the Movement Disorder Society.

[47]  R. Star,et al.  Bioactive exosomes: possibilities for diagnosis and management of bladder cancer. , 2014, The Journal of urology.

[48]  Meg Duroux,et al.  A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy. , 2014, Biochimica et biophysica acta.

[49]  G. Camussi,et al.  Effects of Mesenchymal Stromal Cell-Derived Extracellular Vesicles on Tumor Growth , 2014, Front. Immunol..

[50]  T. Deguchi,et al.  Isolation of prostate cancer-related exosomes. , 2014, Anticancer research.

[51]  R. Schiffelers,et al.  Toward routine detection of extracellular vesicles in clinical samples , 2014, International journal of laboratory hematology.

[52]  K. O'Byrne,et al.  Functions and Therapeutic Roles of Exosomes in Cancer , 2014, Front. Oncol..

[53]  K. Greish,et al.  Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect , 2014, International journal of nanomedicine.

[54]  H. Yin,et al.  Exosomes and Microvesicles: Identification and Targeting By Particle Size and Lipid Chemical Probes , 2014, Chembiochem : a European journal of chemical biology.

[55]  Hakho Lee,et al.  Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor , 2014, Nature Biotechnology.

[56]  P. Ellis,et al.  The use of molecular imaging combined with genomic techniques to understand the heterogeneity in cancer metastasis. , 2014, The British journal of radiology.

[57]  W. Kuo,et al.  Emerging technologies in extracellular vesicle-based molecular diagnostics , 2014, Expert review of molecular diagnostics.

[58]  Samuel A Wickline,et al.  Maximizing exosome colloidal stability following electroporation. , 2014, Analytical biochemistry.

[59]  Jian Song,et al.  A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. , 2014, Biomaterials.

[60]  Maria Ericsson,et al.  Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. , 2014, ACS nano.

[61]  Lynda Chin,et al.  Identification of Double-stranded Genomic DNA Spanning All Chromosomes with Mutated KRAS and p53 DNA in the Serum Exosomes of Patients with Pancreatic Cancer* , 2014, The Journal of Biological Chemistry.

[62]  J. Vandesompele,et al.  The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling , 2014, Journal of extracellular vesicles.

[63]  R. Pink,et al.  Routes and mechanisms of extracellular vesicle uptake , 2014, Journal of extracellular vesicles.

[64]  Cesar M. Castro,et al.  Magnetic nanosensor for detection and profiling of erythrocyte-derived microvesicles. , 2013, ACS nano.

[65]  K. Braeckmans,et al.  Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[66]  Michael Liem,et al.  Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma , 2013, Proteomics.

[67]  Okhil K. Nag,et al.  Surface Engineering of Liposomes for Stealth Behavior , 2013, Pharmaceutics.

[68]  R. Kok,et al.  Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status. , 2013, Advanced drug delivery reviews.

[69]  Keith L Ligon,et al.  Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity , 2013, Molecular therapy. Nucleic acids.

[70]  D. Tang,et al.  Regulation of the Tumor Suppressor PTEN through Exosomes: A Diagnostic Potential for Prostate Cancer , 2013, PloS one.

[71]  Michael Chopp,et al.  Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. , 2013, Cancer letters.

[72]  R. Welti,et al.  Grape exosome-like nanoparticles induce intestinal stem cells and protect mice from DSS-induced colitis. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[73]  S. Thibodeau,et al.  Characterization of human plasma-derived exosomal RNAs by deep sequencing , 2013, BMC Genomics.

[74]  Mattias Belting,et al.  Exosome Uptake Depends on ERK1/2-Heat Shock Protein 27 Signaling and Lipid Raft-mediated Endocytosis Negatively Regulated by Caveolin-1 , 2013, The Journal of Biological Chemistry.

[75]  D. Scadden,et al.  BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. , 2013, The Journal of clinical investigation.

[76]  L. O’Driscoll,et al.  ISEV position paper: extracellular vesicle RNA analysis and bioinformatics , 2013, Journal of extracellular vesicles.

[77]  Lynne T. Bemis,et al.  Standardization of sample collection, isolation and analysis methods in extracellular vesicle research , 2013, Journal of extracellular vesicles.

[78]  Donald J L Jones,et al.  Prolonged Biologically Active Colonic Tissue Levels of Curcumin Achieved After Oral Administration—A Clinical Pilot Study Including Assessment of Patient Acceptability , 2012, Cancer Prevention Research.

[79]  M. Büchler,et al.  Tumor-exosomes and leukocyte activation: an ambivalent crosstalk , 2012, Cell Communication and Signaling.

[80]  Changjin Lee,et al.  Exosomes Mediate the Cytoprotective Action of Mesenchymal Stromal Cells on Hypoxia-Induced Pulmonary Hypertension , 2012, Circulation.

[81]  Hakho Lee,et al.  Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy , 2012, Nature Medicine.

[82]  E. Sverdlov.  Amedeo Avogadro's cry: What is 1 µg of exosomes? , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.

[83]  A. Molinari,et al.  Immune Surveillance Properties of Human NK Cell-Derived Exosomes , 2012, The Journal of Immunology.

[84]  M. Zöller,et al.  Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection. , 2012, The international journal of biochemistry & cell biology.

[85]  Veronica Huber,et al.  Recent advances on the role of tumor exosomes in immunosuppression and disease progression. , 2012, Seminars in cancer biology.

[86]  D. Koppers-Lalic,et al.  Virus-modified exosomes for targeted RNA delivery; A new approach in nanomedicine☆ , 2012, Advanced Drug Delivery Reviews.

[87]  Sidhartha Hazari,et al.  Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298. , 2012, The American journal of pathology.

[88]  Gema Moreno-Bueno,et al.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.

[89]  Per Sunnerhagen,et al.  Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes , 2012, Nucleic acids research.

[90]  R. Schiffelers,et al.  Exosome mimetics: a novel class of drug delivery systems , 2012, International journal of nanomedicine.

[91]  Ling Huang,et al.  Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. , 2012, Cancer letters.

[92]  Guimei Zhang,et al.  Delivery of chemotherapeutic drugs in tumour cell-derived microparticles , 2012, Nature Communications.

[93]  E. Kroh,et al.  Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies , 2011, Cancer Prevention Research.

[94]  W. Hammerschmidt,et al.  EBV-gp350 Confers B-Cell Tropism to Tailored Exosomes and Is a Neo-Antigen in Normal and Malignant B Cells—A New Option for the Treatment of B-CLL , 2011, PloS one.

[95]  Dongmei Sun,et al.  Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[96]  M. Record,et al.  Exosomes as intercellular signalosomes and pharmacological effectors. , 2011, Biochemical pharmacology.

[97]  U. Landegren,et al.  Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer , 2011, Proceedings of the National Academy of Sciences.

[98]  G. Camussi,et al.  Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[99]  M. Wood,et al.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.

[100]  Sujaya Srinivasan,et al.  A Ten-microRNA Expression Signature Predicts Survival in Glioblastoma , 2011, PloS one.

[101]  Beiyi Shen,et al.  Protein Targeting to Exosomes/Microvesicles by Plasma Membrane Anchors* , 2011, The Journal of Biological Chemistry.

[102]  S. Pomeroy,et al.  Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. , 2011, Nature communications.

[103]  T G van Leeuwen,et al.  Optical and non‐optical methods for detection and characterization of microparticles and exosomes , 2010, Journal of thrombosis and haemostasis : JTH.

[104]  M. Chopp,et al.  MiR-146b-5p Suppresses EGFR Expression and Reduces In Vitro Migration and Invasion of Glioma , 2010, Cancer investigation.

[105]  Dongmei Sun,et al.  A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[106]  Seulki Lee,et al.  Activatable molecular probes for cancer imaging. , 2010, Current topics in medicinal chemistry.

[107]  D. Guidolin,et al.  C2C12 myoblasts release micro-vesicles containing mtDNA and proteins involved in signal transduction. , 2010, Experimental cell research.

[108]  Qiang Zhou,et al.  Cellular Internalization of Exosomes Occurs Through Phagocytosis , 2010, Traffic.

[109]  T. D. de Gruijl,et al.  Functional delivery of viral miRNAs via exosomes , 2010, Proceedings of the National Academy of Sciences.

[110]  D. Barh,et al.  Microrna let-7: an emerging next-generation cancer therapeutic , 2010, Current oncology.

[111]  A. Molinari,et al.  Microenvironmental pH Is a Key Factor for Exosome Traffic in Tumor Cells* , 2009, The Journal of Biological Chemistry.

[112]  M. Mason,et al.  Exosomes in tumour immunity , 2009, Current oncology.

[113]  Alessandro Busca,et al.  Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. , 2009, Journal of the American Society of Nephrology : JASN.

[114]  X. Breakefield,et al.  Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer , 2009, British Journal of Cancer.

[115]  Massimo Spada,et al.  High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients , 2009, PloS one.

[116]  Johan Skog,et al.  Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers , 2008, Nature Cell Biology.

[117]  Douglas D. Taylor,et al.  Exosomal microRNA: a diagnostic marker for lung cancer. , 2008, Clinical lung cancer.

[118]  Cicek Gercel-Taylor,et al.  MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. , 2008, Gynecologic oncology.

[119]  A. Guha,et al.  Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells , 2008, Nature Cell Biology.

[120]  L. Ellis,et al.  Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. , 2008, Journal of the National Cancer Institute.

[121]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[122]  P. Paz,et al.  Exosome Display technology: applications to the development of new diagnostics and therapeutics. , 2005, Blood cells, molecules & diseases.

[123]  M. Record,et al.  Characterization of exosome subpopulations from RBL-2H3 cells using fluorescent lipids. , 2005, Blood cells, molecules & diseases.

[124]  Anil K Sood,et al.  Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. , 2005, Cancer research.

[125]  Olivier Lantz,et al.  Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial , 2005, Journal of Translational Medicine.

[126]  J. Le Pecq,et al.  A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer , 2005, Journal of Translational Medicine.

[127]  R. Gaspar,et al.  Use of the Post-Insertion Technique to Insert Peptide Ligands into Pre-Formed Stealth Liposomes with Retention of Binding Activity and Cytotoxicity , 2002, Pharmaceutical Research.

[128]  T. Allen,et al.  In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach. , 2001, Biochimica et biophysica acta.

[129]  D. Andrews,et al.  Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[130]  S. Takeoka,et al.  Poly(ethylene glycol)-modification of the phospholipid vesicles by using the spontaneous incorporation of poly(ethylene glycol)-lipid into the vesicles. , 2000, Bioconjugate chemistry.

[131]  A. Tari,et al.  Safety, pharmacokinetics, and tissue distribution of liposomal P-ethoxy antisense oligonucleotides targeted to Bcl-2. , 1999, The Journal of pharmacology and experimental therapeutics.

[132]  R. Schiffelers,et al.  Localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue: influence of liposome characteristics. , 1999, Biochimica et biophysica acta.

[133]  Laurence Zitvogel,et al.  Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes , 1998, Nature Medicine.

[134]  R. Jain,et al.  Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[135]  J. M. Brown,et al.  Fate of cationic liposomes and their complex with oligonucleotive in vivo , 1996 .

[136]  T. Allen,et al.  Insertion of poly(ethylene glycol) derivatized phospholipid into pre‐formed liposomes results in prolonged in vivo circulation time , 1996, FEBS letters.

[137]  C. Melief,et al.  B lymphocytes secrete antigen-presenting vesicles , 1996, The Journal of experimental medicine.

[138]  C. Hunt,et al.  Retention of cytosine arabinoside in mouse lung following intravenous administration in liposomes of different size. , 1979, Drug metabolism and disposition: the biological fate of chemicals.

[139]  F. Sánchez‐Madrid,et al.  Analysis of microRNA and protein transfer by exosomes during an immune synapse. , 2013, Methods in molecular biology.

[140]  Shinobu Ueda,et al.  Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[141]  J. Au,et al.  Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor. , 2012, Advanced drug delivery reviews.

[142]  S. Yuan,et al.  Pathophysiology and Clinical Relevance , 2010 .

[143]  E. Wisse,et al.  The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer , 2008, Gene Therapy.